Knowledge Base | FAQ

North Carolina Drug and Alcohol Inpatient Treatment Licensing

Flag of North Carolina — North Carolina behavioral health licensing

Written by

A. Ant, CADC-II

in

Author: A. Ant, CADC-II, Licensing & Accreditation Expert

Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

Apply now: DHSR/MHLCS Initial Licensure Application Packet | Questions: (919) 855-3795

Residential SUD treatment in North Carolina is licensed by the Division of Health Service Regulation, Mental Health Licensure and Certification Section (DHSR/MHLCS), and thanks to 2023 reforms, it’s a genuinely more open licensing environment than it used to be.

Certificate of Need No Longer Applies

North Carolina removed a real barrier here recently, and plenty of guidance online still hasn’t caught up to it. Session Law 2023-7, approved March 27, 2023, struck psychiatric facilities and chemical dependency treatment facilities, along with their beds, from the facility and bed lists in G.S. 131E-176(9b) and (9c) that bring a project under Certificate of Need. Before that, adding residential SUD beds meant going through CON review first. That step is gone now. Zoning and standard DHSR/MHLCS licensure requirements still apply in full, so this isn’t a reduction in clinical or physical plant standards, just the removal of a need-based capacity gate that used to slow new development considerably.

Your Application Needs an LME/MCO Letter of Support

Losing the CON step did not take the regional Local Management Entity/Managed Care Organization (LME/MCO) out of the picture. G.S. 122C-23.1 lets DHHS license a new residential treatment facility when the applicant submits a letter of support from the LME for the facility’s catchment area, and that letter has to state the existing bed count and the projected need. 10A NCAC 27G .0406 turns this into an application requirement: the letter goes in with the licensure application for any residential facility that is not subject to CON. Now that chemical dependency facilities are outside CON, we read that as covering every new residential SUD program, and DHSR’s FAQ tells 24-hour residential applicants to take their completed application to the LME-MCO, which issues the letter for the packet. A payer contract with the LME/MCO is a different question. DHSR’s FAQ says you need one only if you plan to bill Medicaid or state funds, and a private-pay provider does not.

Deemed Status Is Narrower Than Many Guides Suggest

Some North Carolina guidance online describes a deemed-status deal for accredited providers with an LME contract, complete with named accreditors and a six-month wait after revocation. None of that is in the statute today. The statute itself, G.S. 122C-22(b), does no more than authorize the Commission to write a deemed-status procedure for facilities certified by a national accrediting agency (its one example is the Joint Commission), and those facilities stay open to the Secretary’s inspections. Under 10A NCAC 27G .0403, the rule written to carry that out, the accrediting agency must be one the Commission has judged to hold standards at least as strict as the state’s, the facility must prove its accreditation to DHSR, and DHSR keeps inspecting. We could not find a published list of accreditors the Commission has approved under .0403, so check with DHSR/MHLCS before building deemed status into a timeline.

ASAM Levels and North Carolina’s Residential Categories

North Carolina does not license residential SUD care by ASAM level number. Rule .3401 describes the residential treatment category as a 24-hour service offering active treatment and a structured living environment in a group setting, for people who have already been detoxified. Withdrawal care has its own license categories: nonhospital medical detoxification under 27G .3100, social setting detoxification under .3200 and outpatient detoxification under .3300. So when a payer or referral source asks whether your house runs at 3.1, 3.5 or 3.7, your DHSR license will not say. The credential that answers that question is the ASAM Level of Care Certification, an ASAM program that providers apply for through CARF, whose surveyors do the on-site review. Right now it is issued only to adult residential programs at Levels 3.1, 3.5 and 3.7, and a referral source can look a site up in CARF’s provider search, where each of the three levels is its own option under the Certification filter. Keep two limits in mind before you build a marketing plan around it. It adds to the DHSR license and does not stand in for it, and the deemed-status statute and rule (G.S. 122C-22 and 27G .0403) are silent on it, so holding it does not get you deemed status. And because it covers only those residential levels, our reading is that it says nothing about withdrawal care: a program that also detoxes clients on site would still need the matching .3100 or .3200 license, since DHSR issues each license for the specific types of service listed on the application.

Medication for Opioid Use Disorder Isn’t Automatically Part of This License

A residential license under 10A NCAC 27G .3400 covers residential treatment, not an opioid treatment program, and DHSR issues each license only for the service types named on the application. North Carolina licenses Opioid Treatment Programs separately, under 10A NCAC 27G .3600, and that process starts somewhere most residential operators don’t expect. DHSR’s application packet and FAQ both say the North Carolina State Opioid Treatment Authority (SOTA) requires a preliminary program approval letter for every service category 3600 facility, so SOTA comes first and the OTP license application follows. Our reading, since the .3600 rule is the one built around methadone, is that a residential program wanting on-site methadone dispensing needs that separate SOTA approval and OTP license, not an assumption that its 27G .3400 license already covers it.

In our experience, most residential programs skip building out full on-site OTP capability and instead coordinate with a nearby licensed OTP (NCDHHS links to a map of OTP providers, mobile units included) or bring in a prescriber for buprenorphine. That second route got simpler when Congress ended the DATA-Waiver program: DEA’s January 12, 2023 letter to registrants says buprenorphine prescriptions now require only a standard DEA registration number. Either approach is clinically workable. Our advice is to write the actual pathway a client would use for medication access into your admission and treatment policies, rather than a general line about referrals being available.

Adding Ketamine to a North Carolina .3400 Residential Program

DHSR’s rules don’t name ketamine. Our conclusions come from the general medication rule in 10A NCAC 27G .0209, the state Controlled Substances Act and the Board of Nursing’s position statements, and MHLCS should confirm them for your program.

Ketamine wouldn’t be a new license category for a .3400 program. It is a medication, and Subchapter 27G handles medication through a single rule, .0209, which allows a drug to be given only on “the written order of a person authorized by law to prescribe drugs” and only by licensed persons or by unlicensed staff trained by a registered nurse. On our reading, an IV infusion or an observed nasal dose is work for licensed clinical staff, not trained aides. Two other parts of .0209 matter here. Paragraph (e)(2) says a facility that “maintains stocks of controlled substances shall be currently registered under the North Carolina Controlled Substances Act,” and paragraph (a)(4) bars keeping a stock of prescription drugs for dispensing without hiring a pharmacist and getting a Board of Pharmacy permit, so keep ketamine to doses given on site. Individual licensed practitioners are exempt from state registration under G.S. 90-101(c)(6), but the facility holding the supply is not covered by that exemption, so plan on a registration with the NCDHHS Drug Control Unit, which publishes a clinic registration form, along with DEA registration at the address (21 CFR 1301.12). Federally, ketamine is a Schedule III depressant (21 CFR 1308.13(c)(7)), and North Carolina lists it in Schedule III at G.S. 90-91(b)(12).

The Reporting System and the Nursing Board

North Carolina’s Controlled Substances Reporting System review mandate is built around opioids. G.S. 90-113.74C makes a practitioner check the system before first prescribing a “targeted controlled substance,” which G.S. 90-87(26a) defines by reference to parts of Schedule II and the narcotic subsection of Schedule III (90-91(d)), not the depressant list where ketamine sits. Even for targeted drugs, the statute makes review optional when the drug is administered in a health care setting or in a residential care facility as G.S. 14-32.2 defines that term. Running the query before the first session is still sound clinical practice.

The only North Carolina Board of Nursing position statement we found that names ketamine is the one on procedural sedation. Last revised September 2022, it says ketamine given for moderate or deep procedural sedation “is not prohibited” when a credentialed practitioner orders it and agency policy allows it, with the ordering provider present and the RN holding ACLS certification. Sub-anesthetic dosing for depression or PTSD goes unmentioned in the Board documents we checked, which leaves an RN-run infusion series as a question to put to the Board itself. A nurse practitioner can order ketamine only under a collaborative practice agreement that covers controlled substances, using the NP’s own DEA number (21 NCAC 36 .0809).

Spravato in a Residential Setting

Esketamine follows different rules. The facility has to be certified in the Spravato REMS, each dose is given under a healthcare provider’s direct supervision, and the patient is monitored for at least two hours afterward. The FDA label lists two uses: treatment-resistant depression, and depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior. Addiction isn’t on that list, and Spravato plays no part in the opioid use disorder medication route covered earlier.

From Residential Bed to Outpatient Clinic

Residents who respond usually need sessions after they leave, and the North Carolina Medical Board takes a strict view of who may own the practice that provides them. Its corporate practice of medicine statement (adopted March 2016, amended September 2025) says a business practicing medicine must be owned in its entirety by North Carolina licensees or a combination G.S. 55B-14 permits, and a 1955 Attorney General opinion given to the Board of Medical Examiners says “A private corporation is prohibited from practicing medicine.” Neither is a statute or a court ruling, and the professional corporation statute (G.S. 55B) limits only who may own a professional corporation, but we wouldn’t build a lay-owned clinic against the Board’s stated position. In practice the clinic is a physician-owned professional corporation or PLLC working with a management services organization, and the details are in North Carolina Drug and Alcohol Outpatient Treatment Licensing.

North Carolina also has its own patient brokering law. The SAFE Act of 2023, codified at G.S. 90-113.152 and effective January 1, 2024, makes it a Class G felony for anyone, a treatment provider or facility included, to pay, solicit or receive anything of value, or split fees, to induce or reward a patient referral. Unlike the federal Eliminating Kickbacks in Recovery Act (18 U.S.C. § 220), its text isn’t tied to services a health care benefit program pays for. A residential program sending patients to a clinic it is affiliated with should have counsel paper that relationship before the first referral.

Staffing a Residential Program

North Carolina’s counselor ladder is the real lever operators have on residential staffing costs. The floor comes from 10A NCAC 27G .3402: one full-time certified alcoholism, drug abuse or substance abuse counselor for up to 30 occupied beds, with another for each additional 30 beds or part of 30; one full-time qualified alcoholism, drug abuse or substance abuse professional (as 27G .0104 defines that term) once you reach 11 occupied beds, plus another for each further 10 beds or part of 10; and at least one staff member in the building whenever clients are there. Putting a Licensed Clinical Addictions Specialist (LCAS) in the clinical director seat is common practice and what we recommend, though the rule itself does not name that role. The state’s addiction credentials run from the Certified Alcohol and Drug Counselor (CADC), who practices under a practice supervisor, up to the LCAS, which requires at least a master’s degree and may practice independently. Both are issued by the North Carolina Addictions Specialist Professional Practice Board and renew every two years.

Round-the-clock coverage adds real cost. A residential program with a clinical director, several counselors, and 24-hour direct-care staff commonly runs well past $350,000 a year in payroll before nursing coverage is factored in. Most of the room to bring that number down sits in how you mix the two credentials. Many North Carolina residential programs staff a meaningful share of direct-care and counseling roles with CADC-level counselors working under an LCAS clinical director, which keeps the program compliant while managing payroll, and pairs an RN with several LPNs for medical oversight rather than staffing every shift with a registered nurse. That specific staffing matrix comes together once census and level of care are confirmed.

How to Submit Your DHSR/MHLCS Application

Download the Initial Licensure Application Packet (Form DHHS/DHSR/MHL5001) from DHSR/MHLCS’s forms page and mail it with the required fee to Division of Health Service Regulation, Mental Health Licensure and Certification Section, 2718 Mail Service Center, Raleigh, NC 27699-2718. For questions on any part of the process, call (919) 855-3795.

What Delays North Carolina Residential Applications

Two mistakes drive most of the real delays here. The most common issue is assuming Certificate of Need still applies and spending time on a process that was eliminated in 2023. The second is leaving the LME/MCO letter of support until the end. For a residential facility, 27G .0406 makes that letter part of the application itself, so an operator who asks for it late ends up waiting on the LME/MCO’s look at bed need before the packet is even complete.

Frequently Asked Questions

How long does it take to open a residential SUD program in North Carolina?

In our experience, plan for roughly 10 to 16 months from initial planning to an issued license. Most of that time goes to the LME/MCO letter of support, staffing readiness, and physical plant standards, not to Certificate of Need review, which no longer applies.

Is Certificate of Need still required for residential SUD facilities in North Carolina?

No. Since Session Law 2023-7 took effect on March 27, 2023, chemical dependency treatment facilities and beds no longer appear on the G.S. 131E-176 lists that Certificate of Need covers.

Does a North Carolina residential SUD license require contacting an LME/MCO?

Yes, for a new residential facility. Your catchment area’s LME/MCO has to write a letter of support (G.S. 122C-23.1 and 10A NCAC 27G .0406), and DHSR wants it inside the initial licensure packet when you file. A payer contract with the LME/MCO is separate and is needed only if you plan to bill Medicaid or state funds.

Want help getting the LME/MCO letter of support and the rest of a North Carolina residential packet in order? Reach out here.

Sources

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

More posts

Top